Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Pharmacology

Background:

• Multitarget compounds, integrating multiple pharmacophores, are a key research area.
• Linker type and length are critical for the efficacy of chimeric molecules.

Purpose of the Study:

• To synthesize and evaluate a novel chimeric compound (1) combining opioid and neurokinin-1 receptor (NK1R) antagonist pharmacophores.
• To investigate the compound's binding affinities, analgesic effects, and potential for blood-brain barrier (BBB) penetration.

Main Methods:

• Synthesis of compound 1 utilizing a hydrazone linker to connect opioid and NK1R antagonist fragments.
• In vitro binding assays to determine affinities for opioid receptors and NK1R.
• In vivo analgesic testing following intrathecal and intravenous administration.
• Molecular modeling to rationalize observed activities.

Main Results:

• Compound 1 exhibited high affinity for μ- and δ-opioid receptors (IC50=12.7 and 74.0 nM) and weak affinity for NK1R.
• In vivo studies demonstrated a strong analgesic effect, indicating potential BBB penetration.
• The hydrazone linker proved effective for rapid and successful chimeric compound synthesis.

Conclusions:

• Compound 1 represents a promising multitarget agent with significant analgesic properties.
• The hydrazone linker is a viable strategy for creating effective chimeric compounds.
• The findings suggest potential therapeutic applications for compound 1 in pain management.